Cargando…
Mechanism-Based Redesign of GAP to Activate Oncogenic Ras
[Image: see text] Ras GTPases play a crucial role in cell signaling pathways. Mutations of the Ras gene occur in about one third of cancerous cell lines and are often associated with detrimental clinical prognosis. Hot spot residues Gly12, Gly13, and Gln61 cover 97% of oncogenic mutations, which imp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515638/ https://www.ncbi.nlm.nih.gov/pubmed/37682266 http://dx.doi.org/10.1021/jacs.3c04330 |
_version_ | 1785108990732009472 |
---|---|
author | Berta, Dénes Gehrke, Sascha Nyíri, Kinga Vértessy, Beáta G. Rosta, Edina |
author_facet | Berta, Dénes Gehrke, Sascha Nyíri, Kinga Vértessy, Beáta G. Rosta, Edina |
author_sort | Berta, Dénes |
collection | PubMed |
description | [Image: see text] Ras GTPases play a crucial role in cell signaling pathways. Mutations of the Ras gene occur in about one third of cancerous cell lines and are often associated with detrimental clinical prognosis. Hot spot residues Gly12, Gly13, and Gln61 cover 97% of oncogenic mutations, which impair the enzymatic activity in Ras. Using QM/MM free energy calculations, we present a two-step mechanism for the GTP hydrolysis catalyzed by the wild-type Ras.GAP complex. We found that the deprotonation of the catalytic water takes place via the Gln61 as a transient Brønsted base. We also determined the reaction profiles for key oncogenic Ras mutants G12D and G12C using QM/MM minimizations, matching the experimentally observed loss of catalytic activity, thereby validating our reaction mechanism. Using the optimized reaction paths, we devised a fast and accurate procedure to design GAP mutants that activate G12D Ras. We replaced GAP residues near the active site and determined the activation barrier for 190 single mutants. We furthermore built a machine learning for ultrafast screening, by fast prediction of the barrier heights, tested both on the single and double mutations. This work demonstrates that fast and accurate screening can be accomplished via QM/MM reaction path optimizations to design protein sequences with increased catalytic activity. Several GAP mutations are predicted to re-enable catalysis in oncogenic G12D, offering a promising avenue to overcome aberrant Ras-driven signal transduction by activating enzymatic activity instead of inhibition. The outlined computational screening protocol is readily applicable for designing ligands and cofactors analogously. |
format | Online Article Text |
id | pubmed-10515638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-105156382023-09-23 Mechanism-Based Redesign of GAP to Activate Oncogenic Ras Berta, Dénes Gehrke, Sascha Nyíri, Kinga Vértessy, Beáta G. Rosta, Edina J Am Chem Soc [Image: see text] Ras GTPases play a crucial role in cell signaling pathways. Mutations of the Ras gene occur in about one third of cancerous cell lines and are often associated with detrimental clinical prognosis. Hot spot residues Gly12, Gly13, and Gln61 cover 97% of oncogenic mutations, which impair the enzymatic activity in Ras. Using QM/MM free energy calculations, we present a two-step mechanism for the GTP hydrolysis catalyzed by the wild-type Ras.GAP complex. We found that the deprotonation of the catalytic water takes place via the Gln61 as a transient Brønsted base. We also determined the reaction profiles for key oncogenic Ras mutants G12D and G12C using QM/MM minimizations, matching the experimentally observed loss of catalytic activity, thereby validating our reaction mechanism. Using the optimized reaction paths, we devised a fast and accurate procedure to design GAP mutants that activate G12D Ras. We replaced GAP residues near the active site and determined the activation barrier for 190 single mutants. We furthermore built a machine learning for ultrafast screening, by fast prediction of the barrier heights, tested both on the single and double mutations. This work demonstrates that fast and accurate screening can be accomplished via QM/MM reaction path optimizations to design protein sequences with increased catalytic activity. Several GAP mutations are predicted to re-enable catalysis in oncogenic G12D, offering a promising avenue to overcome aberrant Ras-driven signal transduction by activating enzymatic activity instead of inhibition. The outlined computational screening protocol is readily applicable for designing ligands and cofactors analogously. American Chemical Society 2023-09-08 /pmc/articles/PMC10515638/ /pubmed/37682266 http://dx.doi.org/10.1021/jacs.3c04330 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Berta, Dénes Gehrke, Sascha Nyíri, Kinga Vértessy, Beáta G. Rosta, Edina Mechanism-Based Redesign of GAP to Activate Oncogenic Ras |
title | Mechanism-Based Redesign
of GAP to Activate Oncogenic
Ras |
title_full | Mechanism-Based Redesign
of GAP to Activate Oncogenic
Ras |
title_fullStr | Mechanism-Based Redesign
of GAP to Activate Oncogenic
Ras |
title_full_unstemmed | Mechanism-Based Redesign
of GAP to Activate Oncogenic
Ras |
title_short | Mechanism-Based Redesign
of GAP to Activate Oncogenic
Ras |
title_sort | mechanism-based redesign
of gap to activate oncogenic
ras |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515638/ https://www.ncbi.nlm.nih.gov/pubmed/37682266 http://dx.doi.org/10.1021/jacs.3c04330 |
work_keys_str_mv | AT bertadenes mechanismbasedredesignofgaptoactivateoncogenicras AT gehrkesascha mechanismbasedredesignofgaptoactivateoncogenicras AT nyirikinga mechanismbasedredesignofgaptoactivateoncogenicras AT vertessybeatag mechanismbasedredesignofgaptoactivateoncogenicras AT rostaedina mechanismbasedredesignofgaptoactivateoncogenicras |